Dual role of immunomodulation by anticancer chemotherapy
暂无分享,去创建一个
[1] Wilfrid Boireau,et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.
[2] G. Shurin,et al. ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents. , 2012, Current medicinal chemistry.
[3] P. Pereira,et al. Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy , 2011, The Journal of experimental medicine.
[4] S. Nakae,et al. Functional specialization of interleukin-17 family members. , 2011, Immunity.
[5] C. Elmets,et al. IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells , 2010, The Journal of Immunology.
[6] B. Saha,et al. Protumor vs Antitumor Functions of IL-171 , 2009, The Journal of Immunology.
[7] W. Zou,et al. Endogenous IL-17 contributes to reduced tumor growth and metastasis. , 2009, Blood.
[8] L. Kaiser,et al. Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity , 2005, Clinical Cancer Research.
[9] E. Jaffee,et al. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. , 2005, Cancer research.
[10] J. Schlom,et al. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. , 2005, Blood.
[11] F. Tanaka,et al. Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor‐specific antitumor effect in vivo , 2002, International journal of cancer.
[12] L. Corcos,et al. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. , 2001, Cancer research.
[13] K. O. Elliston,et al. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.